Neuberger Berman Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-970,841
Closed -$96.4M 1646
2019
Q3
$96.4M Sell
970,841
-188,390
-16% -$17.9M 0.12% 257
2019
Q2
$107M Buy
1,159,231
+45,949
+4% +$4.36M 0.13% 235
2019
Q1
$105M Buy
1,113,282
+842,127
+311% +$73.6M 0.13% 232
2018
Q4
$17.4M Sell
271,155
-136,978
-34% -$10.1M 0.02% 595
2018
Q3
$36.5M Buy
408,133
+10,316
+3% +$912K 0.04% 481
2018
Q2
$31.6M Sell
397,817
-220,158
-36% -$18.3M 0.03% 522
2018
Q1
$55.1M Sell
617,975
-502,273
-45% -$48.2M 0.06% 387
2017
Q4
$117M Sell
1,120,248
-639,777
-36% -$72.2M 0.13% 228
2017
Q3
$257M Sell
1,760,025
-67,748
-4% -$9.23M 0.32% 71
2017
Q2
$237M Sell
1,827,773
-17,064
-0.9% -$2.09M 0.3% 77
2017
Q1
$230M Buy
1,844,837
+71,729
+4% +$8.58M 0.3% 85
2016
Q4
$205M Sell
1,773,108
-527,405
-23% -$58.7M 0.28% 96
2016
Q3
$240M Sell
2,300,513
-147,022
-6% -$15.9M 0.33% 72
2016
Q2
$241M Sell
2,447,535
-121,619
-5% -$12.6M 0.33% 71
2016
Q1
$257M Buy
2,569,154
+1,925,968
+299% +$198M 0.35% 68
2015
Q4
$77M Sell
643,186
-80,685
-11% -$9.33M 0.1% 278
2015
Q3
$78.3M Buy
723,871
+246,849
+52% +$30.6M 0.1% 279
2015
Q2
$55.2M Sell
477,022
-74,178
-13% -$8.48M 0.06% 395
2015
Q1
$63.5M Sell
551,200
-418,582
-43% -$50M 0.07% 373
2014
Q4
$108M Sell
969,782
-252,240
-21% -$26.6M 0.11% 254
2014
Q3
$116M Buy
1,222,022
+11,572
+1% +$1.04M 0.12% 239
2014
Q2
$104M Sell
1,210,450
-49,596
-4% -$3.77M 0.1% 288
2014
Q1
$88M Buy
1,260,046
+208,228
+20% +$16.5M 0.09% 326
2013
Q4
$88.9M Buy
1,051,818
+671,170
+176% +$53.1M 0.09% 328
2013
Q3
$29.3M Buy
380,648
+147,296
+63% +$10.3M 0.03% 530
2013
Q2
$13.6M Buy
+233,352
New +$14M 0.02% 693

Other funds holding CELG

Neuberger Berman Group's CELG Position: Q4 2019 in Review

Neuberger Berman Group sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 970,841 shares — an estimated $96.4M sold.

Neuberger Berman Group first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $257M in Q1 2016. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Neuberger Berman Group reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Neuberger Berman Group sold 970,841 Celgene Corp shares in Q4 2019, an estimated $96.4M.
  • Neuberger Berman Group first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Neuberger Berman Group's Celgene Corp position peaked at $257M in Q1 2016.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Neuberger Berman Group's 13F filing for Q4 2019, filed 12 Feb 2020.